EUVIMEDEUVIMED entdecken
Crossref

PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment

Qin Zheng, Mulin Liu

Clinical and Molecular Hepatology · 06.11.2026

DOI: 10.3350/cmh.2026.0822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Qin Zheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Science….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Biliary tract neoplasmsGenomic analysisPI3K pathwaySystemic treatment

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, Liaoning, China.
  • Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China. liumulin87@126.com.

Zitieren

APA

Zheng, Q., & Liu, M. (2026). PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0822

Vancouver

Zheng Q, Liu M. PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0822

BibTeX
@article{Zheng2026,
  author = {Zheng, Qin and Liu, Mulin},
  title = {PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.0822}
}
Kostenlos starten →